25 of the Best Oncologists Near Me

Carol Ann Huff, M.D., is an Associate Professor of Oncology and Medicine at the Johns Hopkins University School of Medicine and Medical Director for the Johns Hopkins Kimmel Cancer Center. After completing a Bachelor of Science in Zoology at Duke University in Durham, NC, Dr. Huff received her medical degree from Baylor College of Medicine in Houston. She completed her internship and residency in Internal Medicine at Johns Hopkins and was an Assistant Chief of Service in the Department of Medicine before completing her fellowship training in the Department of Oncology at Johns Hopkins University. Dr. Huff is a nationally-recognized expert in the treatment of multiple myeloma and amyloidosis and in the development of new biologically-based treatment strategies. She has sought to better understand the mechanisms for recurrence and the inability to cure these diseases. Through this research, the identification of a myeloma cancer stem cell has emerged, and efforts to target these cells through combination therapy in clinical trials are ongoing. In collaboration with Dr. William Matsui, Dr. Huff has identified a flow cytometric-based blood analysis for multiple myeloma patients that can be used to quantify the number of myeloma cancer stem cells and track how these cells respond to treatment. Their efforts have revealed that changes in the number of myeloma cancer stem cells can predict recurrence in myeloma patients before clinical evidence of recurrence is detectable. Using this blood analysis, as well as growth of these cells from bone marrow samples taken from patients with myeloma, they have begun studying therapeutic strategies to target these cells based on cell surface markers and enzymatic pathways that are important to the survival of myeloma stem cells. Dr. Huff is the recipient of multiple awards for clinical and teaching excellence including the Kimmel Cancer Center's Director’s Teaching Award in Oncology in both 2006 and 2012. During her medical school training, Dr. Huff was the recipient of a Howard Hughes Medical Institute-National Institutes of Health (NIH) fellowship. She has received grant support from the NIH, Multiple Myeloma Research Foundation, and Leukemia and Lymphoma Society. and LLS, and is the principal investigator of numerous investigator-initiated and industry- sponsored clinical trials. She is the author of numerous publications and book chapters not only on multiple myeloma and related disorders, but also on bone marrow transplantation and a range of topics related to internal medicine and oncology. Her current research efforts involve active collaboration with the preclinical laboratories in the development and testing phases of new therapeutic approaches, as well as a lead effort in the national African American Myeloma Consortium seeking to better understand genetic determinants of the disease. Dr. Huff is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, and Plasmacytoma. Dr. Huff is board certified in American Board Of Internal Medicine.

Laura Bukavina is an Oncologist practicing medicine in Cleveland, Ohio. She has been practicing medicine for over 19 years. Dr. Bukavina is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Bukavina is board certified in American Board Of Urology.

My research is focused on breast cancer management, and on care delivery and support for breast cancer patients. Dr. Makower is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Kelly Westbrook is an Oncologist practicing medicine in Durham, North Carolina. She has been practicing medicine for over 22 years. Dr. Westbrook is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Westbrook is board certified in American Board Of Internal Med, Medical Oncology.

Zelia Correa is an Oncologist practicing medicine in Miami, Florida. Dr. Correa is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Choroid Plexus Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Retinoblastoma, and Iridectomy. Dr. Correa is currently accepting new patients.

Carl Landgren is an Oncologist practicing medicine in Coral Gables, Florida. Dr. Landgren is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Bone Marrow Transplant.

Jason Jones, MD, provides expert hematology and oncology treatment for breast cancer patients at Avera Cancer Institute in Sioux Falls, SD. Dr. Jones is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Jones is board certified in Diplomate Of Hematology, American Board Of Internal Medicine; Diplomate Of Medical Oncology, American Board Of Internal Medicine; Diplomate Of Internal Medicine, American Board Of Internal Medicine.

Naushin Shareef is a Hematologist and an Internal Medicine provider practicing medicine in Rockford, Illinois. Dr. Shareef is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Angiosarcoma. Dr. Shareef is board certified in American Board Of Internal Medicine.

Edward Schaeffer is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 25 years. Dr. Schaeffer is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Ureteroscopy. Dr. Schaeffer is board certified in American Board Of Urology - Urology (Certified).

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Waks is board certified in Internal Medicine and Medical Oncology.

Alex Spyropoulos is a Hematologist Oncology provider practicing medicine in New York, New York. Dr. Spyropoulos is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Mesenteric Venous Thrombosis, and Pulmonary Embolism. Dr. Spyropoulos is board certified in American Board Of Internal Medicine.

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Santa is board certified in American Board Of Internal Medicine.

Maysa Abu is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Abu is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Advanced Bronchoscopy. Dr. Abu is board certified in Medical Oncology and Internal Medicine. Dr. Abu is currently accepting new patients.

Neil Iyengar is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 18 years. Dr. Iyengar is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Tongue Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Iyengar is board certified in American Board Of Internal Medicine, 2014.

My goal is to provide the best care possible for patients with blood cancers and their families. I strive to find the best treatment for each patient based on the latest research as well as each patient's own unique situation and goals. I also hope to improve the care of cancer patients through access to clinical trials and ongoing outcomes-based research. My research focuses on physical fitness and cancer patients, survivorship care, and financial toxicity. Dr. Sitlinger is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Sitlinger is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

Keerthi Gogineni is an Oncologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 22 years. Dr. Gogineni is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Gogineni is board certified in American Board Of Internal Medicine, 2010.

Alejandra Perez is an Oncologist practicing medicine in Plantation, Florida. Dr. Perez is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Perez is currently accepting new patients.

Christie Hancock is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Hancock is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Hancock is board certified in American Board Of Internal Medicine, Hematology.

Emmanouil Alimpertis is a Hematologist and an Oncologist practicing medicine in Marinette, Wisconsin. Dr. Alimpertis is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Neuroendocrine Tumor, Familial Prostate Cancer, Prostate Cancer, and Splenectomy. Dr. Alimpertis is board certified in American Board Of Internal Medicine, Hematology.

Phillip Knouse is a Hematologist and an Oncologist practicing medicine in Summit, Wisconsin. He has been practicing medicine for over 10 years. Dr. Knouse is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Knouse is board certified in American Board Of Internal Medicine, Hematology.

Steven Come is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Come is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Come is board certified in American Board Of Internal Medicine.

Dr. Jennifer Ligibel is a Professor at Harvard Medical School, the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and the Director of the Center for Faculty Well-Being at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of lifestyle interventions upon cancer-related outcomes in women with breast cancer. She has conducted a number of studies looking at the impact of exercise and weight loss interventions upon patients’ quality of life and symptoms after cancer diagnosis and is currently leading an NCI-funded Phase III clinical trial that will test the impact of a weight loss intervention upon the risk of disease recurrence in more than 3000 overweight and obese women with early-stage breast cancer. Dr. Ligibel was the Chair of the American Society of Clinical Oncology Subcommittee on Energy Balance, which has developed patient and physician materials to help facilitate healthy lifestyle changes after cancer diagnosis. Dr. Ligibel is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Hormone Replacement Therapy (HRT). Dr. Ligibel is board certified in Medical Oncology.

Marina Baretti, MD, is an assistant professor at Johns Hopkins University School of Medicine and the Jiasheng Chair in Hepato-Biliary Cancer Research. She also serves as Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at the Sidney Kimmel Comprehensive Cancer Center (SKCCC). Dr. Baretti received her medical degree from the University of Pisa in Italy. She completed her internal medicine residency and oncology fellowship at University of Milan. She then went on and completed her Postdoctoral and Medical Oncology Fellowship at Johns Hopkins University, Baltimore, Maryland. She is deeply engaged in bridging the gap between laboratory discoveries and clinical application, working closely with laboratory-based scientists to accelerate the development of novel therapeutic strategies. Her academic research is centered on the development of novel agents in hepatobiliary cancers, with particular interest in combinatorial approaches of immunotherapies. She is currently the principal investigator on multiple clinical trials in FLC, HCC and cholangiocarcinoma at Johns Hopkins University, collaborating closely with laboratory-based researchers to move laboratory findings into patients. Through her work, Dr. Baretti strives to improve outcomes for patients with rare GI cancers by identifying innovative therapies that are informed by a deeper understanding of tumor biology and the tumor microenvironment. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). Dr. Baretti is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, and Pancreatic Cancer.

Charles Geyer, MD, specializes in breast medical oncology and is certified in medical oncology and internal medicine by the American Board of Internal Medicine. He practices at the UPMC Magee Womens Hospital. He completed his medical degree at Texas Tech University Health Science Center, residency at Baylor College of Medicine, chief residency at Baylor College of Medicine and medical oncology fellowship at Baylor College of Medicine. Dr. Geyer is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Febrile Neutropenia, and Menopause. Dr. Geyer is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Geyer is currently accepting new patients.

Dr. Diamond is a hematologist/oncologist who specializes in the treatment of plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. His research interests include utilization of minimal residual disease (MRD)-guided approaches to clinical decision-making, maintenance therapy, and the genomics of multiple myeloma and secondary malignancies that occur in patients treated for multiple myeloma. He completed fellowship at Memorial Sloan Kettering Cancer Center, spending a year as chief fellow, and is a member of the Myeloma Genomics Laboratory at Sylvester Comprehensive Cancer Center. Dr. Diamond is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Relapsed Refractory Multiple Myeloma (RRMM).